MRM:NSD-Medirom Healthcare Technologies Inc (USD)

COMMON STOCK | Personal Services |

Last Closing

USD 2.72

Change

+0.14 (+5.58)%

Market Cap

N/A

Volume

2.30K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-04 )

Largest Industry Peers for Personal Services

Symbol Name Price(Change) Market Cap
FTDR Frontdoor Inc

+0.83 (+1.77%)

USD 3.66B
EM Smart Share Global Ltd ADR

-0.03 (-3.69%)

USD 0.13B
WW WW International Inc

+0.03 (+4.59%)

USD 0.07B
EJH E-Home Household Service Holdi..

-0.02 (-1.96%)

USD 9.66M
IVP Inspire Veterinary Partners, I..

-0.01 (-5.14%)

USD 2.24M
TRNR Interactive Strength Inc. Comm..

-0.01 (-5.39%)

USD 1.40M
SERV Serve Robotics Inc. Common Sto..

+0.87 (+11.01%)

N/A
YYGH YY Group Holding Limited Class..

N/A

N/A

ETFs Containing MRM

N/A

Market Performance

  Market Performance vs. Industry/Classification (Personal Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -52.45% 71% C- 15% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -52.45% 71% C- 15% F
Trailing 12 Months  
Capital Gain -52.78% 75% C 16% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -52.78% 75% C 16% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -11.45% N/A N/A 24% F
Dividend Return -11.45% N/A N/A 23% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 14.73% N/A N/A 83% B
Risk Adjusted Return -77.76% N/A N/A 11% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:

There is nothing we particularly dislike